Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda

Journal of Women's Health

Volumn 16, Issue 7, 2007, Pages 1017-1027

  Allen, Susan ^a,b,c   Stephenson, Rob ^a   Weiss, Heidi ^d   Karita, Etienne ^b,c   Priddy, Frances ^e   Fuller, Laurie ^b,c   Declercq, Andre ^b,c  

^a EMORY UNIVERSITY   (United States)

^b Project San Francisco   (Rwanda)

^c EMORY UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY PLANNING; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; ORAL CONTRACEPTION; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RWANDA; STATISTICAL MODEL; TIME; URBAN POPULATION; WOMEN'S HEALTH;

ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MATERNAL WELFARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRIMARY PREVENTION; RWANDA; URBAN POPULATION; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 34748880200     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0151     Document Type: Article

References (36)

1. United Nations Program on AIDS (UNAIDS). 2004 Report on the global AIDS epidemic: Executive summary. Geneva, Switzerland.
2. Alger LS, Farley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993;82:787.
3. Deschamps MM, Pape JW, Desvarieux M, et al. A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. J Acquir Immune Defic Syndr 1993;6:446.
4. Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM, Bird AG. HIV infection in women: Immunological markers and the influence of pregnancy. AIDS 1995;9:1177.
5. Hock C, Morlat P, Chene G, Dequae L, Dabis F. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidemiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol 1995;86:886.
6. Alliegro MB, Dorrucci M, Phillips AN, et al. Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med 1997;157:2585.
7. Bessinger R, Clark R, Kissinger P, Rice J, Coughlin S. Pregnancy is not associated with the progression of HIV disease in women attending an HIV outpatient program. Am J Epidemiol 1998;147:434.
8. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: A systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998;105:827.
9. Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS: Results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000;14:2355.
10. Minkoff H, Hershow R, Watts DH, et al. The relationship of pregnancy to human immunodeficiency virus disease progression. Am J Obstet Gynecol 2003;189:552.
11. Buskin SE, Diamond C, Hopkins SG. HIV-infected pregnant women and progression of HIV disease. Arch Intern Med 1998;158:1277.
12. Kumar RM, Uduman SA, Khurrana AK. Impact of pregnancy on maternal AIDS. J Reprod Med 1997;42:429.
13. Thongngarm T, Jenkins JK, Ndebele K, McMurray RW. Estrogen and progesterone modulate monocyte cell cycle progression and apoptosis. Am J Reprod Immunol 2003;49:129.
14. Ahdieh L. Pregnancy and infection with human immunodeficiency virus. Clin Obstet Gynecol 2001;44:154.
15. Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: The emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999;3:675.
16. Santiso R. Effects of chronic parasitosis on women's health. Int J Gynaecol Obstet 1997;58:129.
17. Lavrey L, Baeten JM, Martin Jr, HL, et al. Hormonal contraception and risk of HIV-1 acquisition: Results of a 10-year prospective study. The 2nd International AIDS Society Conference on Pathogenesis and Treatment, Paris, July 13-17, 2003.
18. Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 2004;18:205.
19. Lavreys L, Baeten JM, Kreiss JK, et al. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 2004;189:303.
20. Wang CC, Kreiss JK, Reilly M. Risk of HIV infection in oral contraceptive pill users: A meta-analysis. J Acq Immune Defic Syndr 1999;21:51.
21. CIA. 2006. The world fact book: Rwanda. Available at www.cia.gov/cia/ publications/factbook/geos/rw.html Accessed January 3, 2006.
22. Allen S, Van de perre P, Serufilira A, et al. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991;164:67.
23. Allen S, Lindan C, Serufilira A, et al. Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991;266:1657.
24. Allen S, Serufilira A, Gruber V, et al. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health 1993;83:705.
25. Allen S, Serufilira A, Bogaerts J, et al. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA 1992;268:3338.
26. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995;122:262.
27. Lindan CP, Allen S, Serufilira A, et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992;116:320.
28. Kovacs A, Wasserman SS, Burns D, et al. Determinants of human immunodeficiency virus type 1 (HIV-1) shedding in the genital tract of HIV-infected women. Lancet 2001;358:1593.
29. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999;341:385.
30. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial. JAMA 2002;288:189.
31. WHO (2004). HIV transmission through breastfeeding: A review of available evidence. Geneva, Switzerland: World Health Organization. Available at www.unfpa.org/upload/lib_pub_file/276_filename_HIV_PREV_BF_GUIDE_ENG. pdf#search='breastfeeding%20%20transmission%20HIV'
32. Nduati R, Richardson BA, John G, et al. Effect of breastfeeding on mortality among HIV-1 infected women: A randomised trial. Lancet 2001;357:1651.
33. Khun L, Kasonde P, Sinkala M, et al. Prolonged breastfeeding and mortality up to two years post-partum among HIV-positive women in Zambia. AIDS 2005;19:1677.
34. Breastfeeding and HIV International Transmission Study Group. Mortality among HIV-1 infected women according to children's feeding modality: An individual patient meta-analysis. J AIDS 2005;39:430.
35. Coutsoudis A, Coovadi H, Pillay K, Kuhn L. Are HIV-infected women who breastfeed at increased risk of mortality? AIDS 2001;15:653.
36. Jurado RL. Why shouldn't we determine the erythrocyte sedimentation rate? Clin Infect Dis 2001;33:548.